血管内皮生长因子调节缺氧和子宫内膜异位症炎症微环境的机制:基于生物信息学和多层次验证
1Department of Gynaecology, Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei, 430000, China.
Archives of biochemistry and biophysics
|October 12, 2025
概括
血管内皮生长因子 (VEGF) 通过促进炎症和缺氧在子宫内膜异位症中发挥关键作用. 向VEGF可能为这种常见的妇科疾病提供新的治疗策略.
科学领域:
- 妇科 妇科 妇科 妇科
- 分子生物学分子生物学
- 病理生理学 病理生理学
背景情况:
- 子宫内膜异位症是一种常见的妇科疾病,其特征是炎症和HIF-1α升高.
- 驱动子宫内膜异位症进展的精确机制需要进一步阐明.
研究的目的:
- 研究血管内皮生长因子 (VEGF) 在子宫内膜异位症的发病过程中的作用.
- 探索VEGF与子宫内膜异位症中缺氧和炎症的关联.
- 为了确定子宫内膜异位症的潜在治疗点.
主要方法:
- 对基因表达和通路丰富的生物信息分析 (GO,KEGG).
- 在使用12Z细胞的体外研究 (RT-qPCR,西部斑点,ELISA,Transwell,CCK-8测定).
- 胚胎内膜异位症和贝瓦西祖马布治疗的体内大鼠模型;免疫光和细胞因子分析.
主要成果:
- 在子宫内膜异位症中,VEGF表达升高,与HIF1A和IL-33正相关.
- VEGF参与缺氧和与炎症相关的途径.
- 抑制VEGF降低了HIF-1α,IL-33,TNF-α,IL-6,并抑制了细胞的增殖/侵入.
- 贝瓦西祖马布改善了炎症状态,并在体内减少了病变的生长.
结论:
- 在子宫内膜异位症中,VEGF 关键调节缺氧和炎症微环境.
- VEGF是缓解子宫内膜异位症的潜在治疗点.
- 抑制VEGF在控制子宫内膜异位症进展方面表现有前途.
更多相关视频
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
11.7K
07:05TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
5.7K
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Mechanism of Angiogenesis
6.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.7K
